These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11532387)

  • 1. Withdrawal-emergent rabbit syndrome during dose reduction of risperidone.
    Nishimura K; Tsuka M; Horikawa N
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):323-4. PubMed ID: 11532387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit syndrome secondary to risperidone.
    Hoy JS; Alexander B
    Pharmacotherapy; 2002 Apr; 22(4):513-5. PubMed ID: 11939686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone and neuroleptic malignant syndrome.
    Tarsy D
    JAMA; 1996 Feb; 275(6):446. PubMed ID: 8627964
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant neuroleptic syndrome associated to risperidone].
    Aguirre C; García Monco JC; Mendibil B
    Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risperidone].
    Zolk O; Thürauf N
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745
    [No Abstract]   [Full Text] [Related]  

  • 7. Withdrawal-emergent dyskinesia in a patient taking risperidone/citalopram.
    Miller LJ
    Ann Pharmacother; 2000 Feb; 34(2):269. PubMed ID: 10676841
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy.
    Yamada Y; Ohno Y; Nakashima Y; Fukuda M; Takayanagi R; Sato H; Tsuchiya F; Sawada Y; Iga T
    Synapse; 2002 Oct; 46(1):32-7. PubMed ID: 12211096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the extrapyramidal side-effects of antipsychotics with combined dopamine and 5-HT-blocking effects.
    Sher L
    Med Hypotheses; 1998 Mar; 50(3):267-8. PubMed ID: 9578333
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome.
    Vurucu S; Congologlu A; Altun D; Unay B; Akin R
    J Natl Med Assoc; 2009 Mar; 101(3):273-5. PubMed ID: 19331262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone withdrawal-related respiratory dyskinesia: a case diagnosed by spirography and fibroscopy.
    Komatsu S; Kirino E; Inoue Y; Arai H
    Clin Neuropharmacol; 2005; 28(2):90-3. PubMed ID: 15795553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotension and orthostasis following a risperidone overdose.
    Himstreet JE; Daya M
    Ann Pharmacother; 1998 Feb; 32(2):267. PubMed ID: 9496415
    [No Abstract]   [Full Text] [Related]  

  • 14. Extrapyramidal symptoms in patients treated with risperidone.
    Simpson GM; Lindenmayer JP
    J Clin Psychopharmacol; 1997 Jun; 17(3):194-201. PubMed ID: 9169965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperprolactinemia induced by neuroleptics].
    Lakartidningen; 2007 May 9-15; 104(19):1522. PubMed ID: 17550031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extrapyramidal syndrome].
    Nakagawa S; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):179-82. PubMed ID: 12876960
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates.
    Casey DE
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S55-9. PubMed ID: 7831441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients.
    Gassó P; Mas S; Oliveira C; Bioque M; Parellada E; Bernardo M; Trias G; Comeche J; Lafuente A
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):294-9. PubMed ID: 20619616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone-induced extrapyramidal reactions.
    Mahmood T; Clothier EB; Bridgman R
    Lancet; 1995 Nov; 346(8984):1226. PubMed ID: 7475677
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.